In February 2026, Icelandair transported 289 thousand passengers, 15% more than in February last year. Passenger distribution in February was as follows: 42% were traveling to Iceland, 21% from ...
Things pass by incredibly swiftly in the Bigger and Boulder trailer. So it can be difficult to catch some of the new features. The Dead Cells and Palworld first Terraria crossover references come up ...
A brand new episode of the recently introduced reality game show series, Fear Factor: House of Fear, premieres on Fox Wednesday, Jan. 21 at 9/8c. During this week’s new episode, this season’s round of ...
MEXICO CITY, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) ...
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the ...
Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet cell transplant. The procedure creates a hybrid immune system that stops ...
Scientists analyzing human and mouse pancreatic lymph nodes (PLNs) and spleens have identified a distinct subset of CD4 memory helper T cells associated with type 1 diabetes (T1D). Reported by ...
When Amanda Smith walked into the kitchen one night in 2015 to warm up a bottle for her four-month-old daughter, she couldn’t make out the numbers on the microwave. They were blurry. They’d never been ...
I’m already loving this device, and I haven’t even touched one. Arduino announced it has collaborated with M5Stack to develop the new compact and powerful Nesso N1 IoT development kit. This system ...
AI virtual cells outperform key baselines on well-calibrated metrics, challenging prior reports of poor model performance Foundational research reinforces the use of virtual cell models to accelerate ...
Although chimeric antigen receptor (CAR) T cell therapy has revolutionized treatment for hematologic malignancies, insufficient CAR-T cell persistence remains a major limitation. T cell factor 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results